Goldman Sachs’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $419K | Buy |
136,378
+31,918
| +31% | +$98K | ﹤0.01% | 4350 |
|
|
2025
Q1 | $202K | Sell |
104,460
-9,014
| -8% | -$17.4K | ﹤0.01% | 4679 |
|
|
2024
Q4 | $424K | Buy |
113,474
+33,671
| +42% | +$126K | ﹤0.01% | 4374 |
|
|
2024
Q3 | $390K | Buy |
79,803
+17,513
| +28% | +$85.6K | ﹤0.01% | 4238 |
|
|
2024
Q2 | $467K | Buy |
+62,290
| New | +$467K | ﹤0.01% | 3994 |
|